Cyclosporine-associated hyperkalemia: Report of four allogeneic blood stem-cell transplant cases

Transplantation

Volumn 75, Issue 7, 2003, Pages 1069-1072

  Caliskan, Yasar ^a   Kalayoglu Besisik, Sevgi ^a,b   Sargin, Deniz ^a   Ecder, Tevfik ^a  

^a Section of Pediatric Epileptology and Video EEG Lab Acibadem   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLAVOXATE; FLUCONAZOLE; FOLINATE CALCIUM; METHOTREXATE; METRONIDAZOLE; PHENIRAMINE MALEATE; RANITIDINE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DISEASE SEVERITY; DRUG BLOOD LEVEL; ELECTROLYTE DISTURBANCE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERKALEMIA; HYPOALDOSTERONISM; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; LEUKEMIA; MALE; NEPHROTOXICITY; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0037446713     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000057241.69355.59     Document Type: Article

References (22)

1. Powles RL, Barret AJ, Clink H, et al. Cyclosporine A for the treatment of graft-versus-host disease in man. Lancet 1978; 2: 1327.
2. Yee GC, Self SG, McGuire TR, et al. Serum cyclosporine concentrations and risk of acute graft-versus-host disease after allogeneic marrow transplantation. N Engl J Med 1988; 319: 65.
3. Deeg HJ, Storb R, Thomas ED, et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 1985; 65: 1325.
4. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443.
5. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Oxford, Blackwell 1994, p 339.
6. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
7. Shulman H, Striker G, Deeg HJ, et al. Nephrotoxicity of cyclosporine A after allogeneic marrow transplantation. N Engl J Med 1981; 305: 1392.
8. Melby JC, Azar ST. Hypoaldosteronism and mineralocorticoid resistance. In: De Groot LJ, et al. Endocrinology [ed. 4]. Philadelphia, Saunders 2000, p 1845.
9. Fleming DR, Ouseph R, Herrington J. Hyperkalemia associated with cyclosporine (CsA) use in bone marrow transplantation. Bone Marrow Transplant 1997; 19: 289.
10. Pei Y, Richardson R, Greenwood C, et al. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients. Am J Kidney Dis 1993; 22: 314.
11. Kamel KS, Ethier JH, Quaggin S, et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol 1992; 2: 1279.
12. Goldman MH, Barhart G, Mohana-Kumar T, et al. Cyclosporine in cardiac transplantation. Surg Clin North Am 1985; 65: 637.
13. Cockcroft SW, Gault HM. Prediction of creatinine clearances from serum creatinine. Nephron 1976; 16: 31.
14. Ringden O. Cyclosporine in allogeneic bone marrow transplantation. Transplantation 1986; 42: 445.
15. Yee GC. Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation. Transplant Proc 1990; 22: 1327.
16. Parikh CR, McSweeney PA, Korular D, et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 2002; 62: 566.
17. Hows JM, Chipping PM, Fairhead S, et al. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporine A. Br J Haematol 1983; 54: 69.
18. Atkinson K, Downs K, Ashby M, et al. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays. Transplant Proc 1990; 22: 1331.
19. Aguilara S, Deray G, Desjobert H, et al. Effects of cyclosporine on tubular acidification function in patients with idiopathic uveitis. Am J Nephrol 1992; 12: 425.
20. Woo M, Przepiorka D, Ippoliti J, et al. Toxicities of tacrolimus and cyclosporine A after allogeneic blood stem cell transplantation. Bone Marrow Transplant 1997; 20: 1095.
21. + balance. In: Brenner BM, Rector S. The Kidney [6th ed]. Philadelphia, Saunders 2000, p 956.
22. +-ATPase activity by cyclosporine A. Kidney Int 1993; 43: 246.